Table 3.

 Clinical symptoms in HCoV‐NL63‐positive patients without a second respiratory infection ^*

Country	Fever	Cough	Coryza/ rhinorrhoea	Pharyngitis/sore throat/ hoarseness	Bronchitis/ Bronchiolitis	Pneumonia	Croup	Underlying disease	Kawasaki disease	Reference
Netherlands (n=4)	50 †	50	75	ND	0	0	0	100	0	Fouchier et al. (2004)
Australia (n=10)	70	70	60	50	50	0	10	30	0	Arden et al. (2005)
Canada I (n=19)	79	47	10	26	10	0	5	5	0	Bastien et al. (2005a)
Belgium (n=5)	80	60	20	20	60‡	0	0	80	0	Moes et al. (2005)
Hong Kong (n=12)	18	73	64	27	0	0	27	27	0	Chiu et al. (2005)
France (n=18) §	61	ND	39	22	33	5	0	5	0	Vabret et al. (2005)
Canada II (n=24)	30	58	42	8	46	4	4	69	0	Bastien et al. (2005b)

^* Negative for RSV PIV1‐3 influenza A and B and adenovirus. Some groups tested for additional pathogens: hMPV (2005, 2005a, 2005b, 2005, 2004), HCoV‐229E and HCoV‐OC43 (2005, 2004), PIV4 (2004, 2005) and rhinovirus (Fouchier et al., 2004).

^† Percentage of HCoV‐NL63 patients with indicated symptom.

^‡ Lower respiratory tract illness nonpneumonia.

^§ Medical records were available for 18 of the 28 patients.

ND, not determined; HCoV, human coronavirus.